Synthesis and Biological Evaluation of Benzimidazoles as Target for α-Glucosidase Inhibitors
Abstract
Diabetes mellitus is rising globally touching more than 180 million people worldwide. This is prevailing mostly in type 2 diabetes and according to WHO report the incidence is likely to be more than doubled by 2030. α-glucosidase inhibitors work by reducing the amount of glucose that the intestines absorb from food. In our previous work, forty-five benzimidazoles analogues were studied using 3D QSAR, HQSAR, and Pharmacophore mapping and based on their results 60 compounds were designed. Docking studies of those designed compounds showed that most of the compounds are bonding with important amino acids LEU 520, ARG 335 and ASP 69 through hydrogen bonds and steric interaction. In this work, synthesis of eleven compounds was done on the basis of molecular docking studies. Compounds containing hydroxyl and alkyl groups (compound no. 3, 9 and 10) were found to be five to eight folds more active with IC90 values in the range of 6.02 ± 1.10 to 33.25 ± 1.20 µg/ml, in comparison with the standard drug, Acarbose (IC90= 290.55 ± 0.081 µg/ml). Thus, these compounds after the toxicity studies could be of therapeutic use in treating diabetes.
Keywords: Acarbose, Alpha-glucosidase inhibition, Benzimidazoles, Docking, Molecular modelling, Post-prandial hyperglycemia
Keywords:
Acarbose, Alpha-glucosidase inhibition, Benzimidazoles, Docking, Molecular modelling, Post-prandial hyperglycemia, Acarbose, Alpalpha-glucosidase inhibition, Benzimidazoles, Docking, Molecular modelling, Post-prandial hyperglycemiaDOI
https://doi.org/10.22270/jddt.v10i2-s.4019References
Global report on diabetes. WHO, Geneva, 2016.
Mathers CD, Loncar D. Projections of global mortality and burden of diseases from 2002 to 2030. Plos Med, 2006; 3(11):442.
Alberti K, Zimmet Z. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. 1999; 1:125.
Kalra S. Alpha glucosidase inhibitors. J. Pak Med. Assoc. 2014; 64(4):474-476.
Hanefeld M, Schaper F. The role of Alpha-Glucosidase Inhibitors (Acarbose). Pharmacotherapy of Diabetes: New Developments. Diabetes: Endocrinology. US Springer, 2007; 143-52.
A.N. Aziz, M. Taha, N.H. Ismail, E.H. Anouar, S. Yousuf, W. Jamil, K. Awang, N. Ahmat, K.M. Khan, S.M. Kashif, Synthesis, crystal structure, DFT studies and evaluation of the antioxidant activity of 3,4-dimethoxybenzenamine schiff bases, Molecules, 2014; 19:8414-8433
S. Imran, M. Taha, N.H. Ismail, K.M. Khan, F. Naz, M. Hussain, S. Tauseef, Synthesis of novel bisindolylmethane schiff bases and their antibacterial activity Molecules, 2014; 19:11722-11740
W. Jamil, S. Perveen, S.A.A. Shah, M. Taha, N.H. Ismail, S. Perveen, N. Ambreen, K.M. Khan, M.I. Choudhary, Phenoxyacetohydrazide schiff bases: β-glucuronidase inhibitors, Molecules, 2014; 19:8788-8802
Jamil, W., Solangi, S., Ali, M., Khan, K.M., Taha, M., Khuhawar, M.Y., 2015 Syntheses, Characterization, In Vitro Antiglycation and DPPH Radical Scavenging Activities of Isatin Salicylhydrazidehydrazone and its Mn (II), Co (II), Ni (II), Cu (II), and Zn (II) Metal Complexes. Arabian J. Chem. (http://dx.doi.org/10.1016/j.arabjc.2015.02.015) (in press).
K.M. Khan, M. Taha, F. Naz, S. Siddiqui, S. Ali, F. Rahim, S. Perveen, M.I. ChoudharyAcylhydrazide Schiff bases: DPPH radical and superoxide anion scavengers, Med. Chem., 2012; 8:705-710
K.M. Khan, M. Taha, F. Rahim, M.I. Fakhri, S. Rasheed, F. Rahim, W. Jamil, M. Khan, A. Karim, S. Perveen, M.I. choudharyAcylhydrazide schiff bases: synthesis and antiglycation activity, J. Chem. Soc. Pak., 2013; 35:930-938
K.M. Khan, F. Rahim, N. Ambreen, M. Taha, M. Khan., H. Jahan, Najeebullah, A. Shaikh, S. Iqbal, S. Perveen, M.I. Choudhary, Synthesis of benzophenonehydrazone Schiff bases and their in vitro antiglycating activities, Med. Chem., 2013; 9:588-595
K.M. Khan, M. Irfan, M. Ashraf, M. Taha, S.M. Saad, S. Perveen, M.I. Choudhary, Synthesis of phenyl thiazole hydrazones and their activity against glycation of proteins, Med. Chem. Res., 2015; 24:3077-3085
M. Taha, N.H. Ismail, M. Ali, K.M. Khan, W. Jamil, S.M. Kashif, M. Asraf, Synthesis of indole-2-hydrazones in search of potential leishmanicidal agents, Med. Chem. Res., 2014; 23:5282-5293
M. Taha, N.H. Ismail, A. Khan, A.A.S. Syed, A. Anwar, S.A. Halim, M.Q. Fatmi, S. Imran, F. Rahim, K.M. Khan, Synthesis of novel derivatives of oxindole, their urease inhibition and molecular docking studies, Bioorg. Med. Chem. Lett., 2015; 25:3285-3289
M. Taha, N.H. Ismail, M.S. Baharudin, S. Lalani, S. Mehboob, K.M. Khan, S. yousuf, S. Siddiqui, F. Rahim, M.I. Choudhary, Synthesis crystal structure of 2-methoxybenzoylhydrazones and evaluation of their a-glucosidase and urease inhibition potential, Med. Chem. Res., 2015; 24:1310-1324
M. Taha, N.H. Ismail, S. Imran, M.Q.B. Rokei, S.M. Saad, K.M. KhanSynthesis of new oxadiazole derivatives as α-glucosidase inhibitors, Bioorg. Med. Chem., 2015; 23:4155-4162
Kohno T, Ohtaka H, Tsukamoto G, Yoshino K: Synthesis and anti-inflammatory activity of some 2- (substituted-pyridinyl) benzimidazoles. Journal of Medicinal Chemistry 1980, 23:734-738.
Bhise UN, Kumar SBV, Ramanatham V, Vaidya SD: Synthesis, antibacterial, anti-asthmatic and antidiabetic activities of novel N-substituted benzimidazoles. European Journal of Medicinal Chemistry 2008, 43(5):986-995.
Francisco AC, Gabriel NV, Hermenegilda MD: Design, microwave-assisted synthesis and spasmolytic activity of 2-(alkyloxyaryl)-1H-benzimidazole derivatives as constrained stilbene bioisosteres. Bioorganic and Medicinal Chemistry Letters 2006, 16(16):4169-4173.
Pashinski VG, Romanova TV, Mukhina NA, Shkrabova LV: Diuretic activity of benzimidazole urea derivatives. Farmakol Toksikol 1978, 41(2):196-9.
Durmaz R, Gunal S, Kucukbay H: Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds. Science Direct: II Farmaco 2003, 58:431-437.
Solominova PS, Pilyugin VS, Pyurin AA: Targated search for new anthelmentic among 5 (6- Aminophenylthio (oxy)-2-amino benzimidazole derivatives. Journal of Pharmaceutical Chemistry 2004, 38:425-430.
Gardiner JM, Loyns CR, Burke A, Khan A: Synthesis and HIV -1 inhibition of novel benzimidazole derivatives. Bioorganic and Medicinal Chemistry Letters 1995, 5(12):1251-1254.
Bariwal JB, Shah AK, Kathiravan MK, Somani RS, Jagtap JR: Synthesis and antiulcer activity of novel pyrimidylthiomethyl and Pyrimidylsulfinylmethyl benzimidazoles as potential reversible proton pump inhibitors. Indian Journal of Pharmaceutical Education and Research 2008, 42(3):225-231.
Durmaz R, Gunal S, Kucukbay H: Synthesis, antibacterial and antifungal activities of electron-rich olefins derived benzimidazole compounds. Science Direct: II Farmaco 2003, 58:431-437.
Chimrri A, Sarro AD, Sarro GD, Giho G, Zappala M: Synthesis and anticonvulsant properties of 2, 3, 3a-4-tetrahydro-1-H pyrrolo (1,2-a) benzimidazol-1-one derivatives. Science Direct: II Farmaco 2001, 56(11):821-826.
Zawawi et al. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies. Bioorganic Chemistry J. 2016; 64: 29–36.
Taha M. Synthesis crystal structure of 2-methoxybenzoylhydrazones and evaluation of their α-glucosidase and urease inhibition potential. Medicinal chemistry research J. 2015, 24; 3:1310-1324.
Taha M. Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities. European Journal of Medicinal Chemistry. 2014; 84:731-738.
Panda SS. Synthesis of 2-arylbenzimidazoles in water. Taylor and Francis J. 2011; 729-735.DOI: 10.1080/00397911003642682.
Taha M. Antiglycation and antioxidant potential of novel imidazo [4, 5-b] pyridine benzohydrazones. Arabian journal of chemistry. 2015; 1878-5352. http://dx.doi.org/10.1016/j.arabjc.2015.08.004
Rostamizadeh S et al. Very fast and efficient synthesis of some novel substituted 2-arylbenzimidazoles in water using ZrOCl2.nH2O on montmorillonite K10 as catalyst. Monatsh Chem Springer. 2009; 140:547–552.
Kiumars Bahrami. Mild and highly efficient method for the synthesis of 2-Arylbenzimidazoles and 2-Arylbenzothiazoles. JOC. 2008; 73:6835-6837.
Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).